- Connecticut Comprehensive Drug Laws - This reference guide was prepared by the Connecticut Department of Consumer Protection’s Drug Control Division to provide pertinent state statutes and regulations related to pharmaceuticals in one place, for easy access and enhanced continuity.
- New Laws - Information about recently passed legislation related to drug control.
- Connecticut Laws Impacting Prescribing and Practice - Highlights of Connecticut laws that have been updated in recent years to reflect changes in prescribing practices for controlled substances and opioid medications.
- Perpetual Inventory - Section 5 of Public Act 18-16 added a requirement for a pharmacy and an institutional pharmacy to maintain a perpetual inventory for all Schedule II controlled substances.
Relevant State Statutes
- Pure Food & Drug Act, Chapter 417
- Uniform Food Drug & Cosmetic Act, Chapter 418
- Retail Drug Control Act, Chapter 419
- Dependency Producing Drugs Act, Chapter 420b
- Controlled Substance Registration Act, Chapter 420c
- Pharmacy, Chapter 400j
- Continuing Education Requirement for Pharmacists, 20-600
State Regulations
- Regulations on the Practice of Pharmacy (Sec. 20-576)
- Regulations on Electronic Data Intermediaries (Sec. 20-614)
- Regulations on the Administration of Vaccine by Pharmacists (Sec. 20-633)
- Regulations on Quality Assurance Programs for Pharmacies (Sec. 20-635)
- Regulations on Storage and Retrieval of Prescription Information for Controlled Substances (Sec. 21a-244)
- Regulations on Record Keeping for Controlled Drugs (Sec. 21a-254)
- Regulations on Minimum Security and Safeguards for Storage, Handling of Controlled Substances (Sec. 21a-262)
- Regulations on Drug Enforcement and Safe Neighborhoods Programs (Sec. 21a-274a)
- Regulations on Registration of Practitioners for Controlled Substances (Sec. 21a-326)
- Regulations on Banned Hazardous Substances (Sec. 21a-336)
- Regulations on Repurchase of Banned Hazardous Substances (Sec. 21a-342)
- Regulations on Connecticut Food, Drug and Cosmetic Act (Sec. 21a-115)
- Regulations on Safe Handling, Disposal of Hypodermic Needles and Syringes (Sec. 21a-66)
- Regulations on Designation of Controlled Substances (Sec. 21a-243)
- Regulations on Non-Sterile Compounding (Sec. 20-576, 69-73)
- Regulations on Sterile Compounding (Sec. 20-576, 64-68)
- Regulations on Registration of Pharmacy Interns (Sec. 20-576-8)
- Regulations on Collaborative Drug Therapy Management (Sec. 20-631)
- Regulations on Emergency and Hormonal Contraception (Sec. 20-633k)
- Regulations on Nonlegend Vending Machines (Sec. 20-576-31)
Adult-Use Cannabis
- Regulation of Adult-Use Cannabis, Chapter 420h
- Policies and Procedures for the Regulation of Adult Use Cannabis
Medical Marijuana
- Regulations on the Palliative Use of Marijuana, Chapter 420f
- Regulations on the Practice of Pharmacy (Sec. 20-576)
- Regulations on Electronic Data Intermediaries (Sec. 20-614)
- Regulations on the Administration of Vaccine by Pharmacists (Sec. 20-633)
- Regulations on Quality Assurance Programs for Pharmacies (Sec. 20-635)
- Regulations on Storage and Retrieval of Prescription Information for Controlled Substances (Sec. 21a-244)
- Regulations on Record Keeping for Controlled Drugs (Sec. 21a-254)
- Regulations on Minimum Security and Safeguards for Storage, Handling of Controlled Substances (Sec. 21a-262)
- Regulations on Drug Enforcement and Safe Neighborhoods Programs (Sec. 21a-274a)
- Regulations on Registration of Practitioners for Controlled Substances (Sec. 21a-326)
- Regulations on Banned Hazardous Substances (Sec. 21a-336)
- Regulations on Repurchase of Banned Hazardous Substances (Sec. 21a-342)
- Regulations on Connecticut Food, Drug and Cosmetic Act (Sec. 21a-115)
- Regulations on Safe Handling, Disposal of Hypodermic Needles and Syringes (Sec. 21a-66)
- Regulations on Designation of Controlled Substances (Sec. 21a-243)
- Regulations on Non-Sterile Compounding (Sec. 20-576, 69-73)
- Regulations on Sterile Compounding (Sec. 20-576, 64-68)
- Regulations on Registration of Pharmacy Interns (Sec. 20-576-8)
- Regulations on Collaborative Drug Therapy Management (Sec. 20-631)